CRUK/MRC Gray Institute for Radiation Oncology and Biology, Department of Oncology, University of Oxford, Oxford, UK.
Semin Cell Dev Biol. 2011 Oct;22(8):886-97. doi: 10.1016/j.semcdb.2011.10.007. Epub 2011 Oct 17.
Chromosomal rearrangements, which can lead to oncogene activation and tumour suppressor loss, are a hallmark of cancer cells. Such outcomes can result from both the repair and misrepair of DNA ends, which arise from a variety of lesions including DNA double strand breaks (DSBs), collapsed replication forks and dysfunctional telomeres. Here we review the mechanisms by which non-homologous end joining (NHEJ) and homologous recombination (HR) repair pathways can both promote chromosomal rearrangements and also suppress them in response to such lesions, in accordance with their increasingly recognised tumour suppressor function. Further, we consider how chromosomal rearrangements, together with a modular approach towards understanding their etiology, may be exploited for cancer therapy.
染色体重排可导致癌基因激活和肿瘤抑制基因丢失,是癌细胞的一个标志。这些结果可能是由 DNA 末端的修复和错误修复引起的,这些末端来自包括 DNA 双链断裂 (DSBs)、复制叉崩溃和功能失调的端粒在内的各种损伤。在这里,我们回顾了非同源末端连接 (NHEJ) 和同源重组 (HR) 修复途径的机制,这些机制既可以促进染色体重排,又可以根据它们日益被认可的肿瘤抑制功能,对这些损伤做出反应来抑制染色体重排。此外,我们还考虑了染色体重排以及理解其病因的模块化方法如何被用于癌症治疗。